SCHEMBL7082338

SCHEMBL7082338

Cc1ccc(C(=O)c2ccc(N)cc2Cl)o1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 4/20 0.43
CYP3A4 P08684 2/20 0.41
JAK2 O60674 1/20 0.40
TYK2 P29597 1/20 0.40
MAOA P21397 3/20 0.40
CHRM2 P08172 1/20 0.40
CHRM3 P20309 1/20 0.40
HTR2C P28335 1/20 0.40
CHRNA4 P43681 1/20 0.40
HTR3A P46098 1/20 0.40
KCNH2 Q12809 1/20 0.40
HRH3 Q9Y5N1 1/20 0.40
MAOB P27338 2/20 0.38
FLT3 P36888 1/20 0.38
KLK7 P49862 1/20 0.38
ALDH1A1 P00352 3/20 0.38
ALOX15 P16050 2/20 0.38
NR1H4 Q96RI1 1/20 0.38
MAPT P10636 1/20 0.38
KDM4E B2RXH2 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7090488 0.78 JAK2 (0.53) HPGDCYP3A4JAK2TYK2MAOA
SCHEMBL7074418 0.77 KMT2A (0.55) ALDH1A1MAPTKDM4EHSD17B10POLB
SCHEMBL8305811 0.74 GFER (0.61) JAK2TYK2ALDH1A1MAPTKDM4E
SCHEMBL29088628 0.73 MAPT (0.51) HPGDCYP3A4JAK2TYK2ALDH1A1
SCHEMBL7035012 0.73 CYP3A4 (0.48) HPGDCYP3A4JAK2TYK2MAOA
SCHEMBL7079315 0.72 MAPK14 (0.70) HPGDKLK7ALDH1A1ALOX15MAPT
SCHEMBL5174662 0.72 RAB9A (0.48) CYP3A4JAK2TYK2ALDH1A1MAPT
SCHEMBL5172393 0.72 MAPK13 (0.61) CYP3A4ALDH1A1RECQL
SCHEMBL6654572 0.72 CYP3A4 (0.47) HPGDCYP3A4JAK2TYK2MAOA
SCHEMBL10659112 0.72 POLB (0.43) HPGDMAOAMAOBKLK7ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030073832-A1 Novel aminophenyl ketone derivatives LEO PHARMACEUTICAL PRODUCTS LTD. A/S (DK) 2003-04-17 US disclosed
WO-2002083622-A2 NOVEL AMINOPHENYL KETONE DERIVATIVES LEO PHARMA A/S (DK) 2002-10-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030073832-A1 Novel aminophenyl ketone derivatives MAPKAPK2, MAP3K2, MAP3K1 HPGD 902/4885CYP3A4 1544/4885JAK2 595/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.